SIRT5 Deacylation Specificity: From Structural Insights and Pathophysiological Functions to Modulator Development
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01808 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Wenyi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Provincial Engineering Research Center of Molecular Targeted Diagnostic & Therapeutic Drugs, School of Food and Bio-engineering, Xihua Univer…. Hauptthemen laut MEDLINE: Sirtuins. Die Arbeit nennt 140 Literaturangaben. Gefördert von: Sichuan Higher Education Talent Training Quality and Teaching Reform Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
SIRT5 is a key deacylase that specifically catalyzes desuccinylation, demalonylation, and deglutarylation, participating in glycolysis, mitochondrial energy metabolism, and oxidative stress, and represents a promising target for disease intervention.The “acidic acyl-binding groove (AABG)” formed by Tyr102 and Arg105 in the catalytic pocket of SIRT5 acts as the core structure for specific recognition of acidically acylated substrates. Modulators binding to this groove through hydrogen bonds and/or electrostatic interactions and a salt bridge generally exhibit superior activity and selectivity. Focusing on the AABG, this paper systematically reviews the latest advances in SIRT5 concerning its protein structure, specific deacidicacylation mechanism, pathophysiological functions and modulator development. It mainly illustrates the strategies and binding modes of modulators designed based on the anchoring effect of the groove, aiming to provide comprehensive theoretical references for exploring the molecular functions of SIRT5 and advancing the research of targeted therapeutic drugs. This perspective systematically elaborates SIRT5’s unique acidic acyl-binding pocket mechanism, sorts modulators by Tyr102/Arg105 anchoring mode, clarifies its bidirectional disease roles, and proposes novel selective modulator design strategies to advance SIRT5-targeted precision drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Provincial Engineering Research Center of Molecular Targeted Diagnostic & Therapeutic Drugs, School of Food and Bio-engineering, Xihua University, Chengdu610039, China.
- Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong518000, China.
- Aier Eye Hospital, Tianjin University, No.102, Fukang Road, Nankai District, Tianjin300110, China.
- Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu610041, China.
ORCID-Profile: Guo-Bo Li, Lingling Yang
Förderung
- Sichuan Higher Education Talent Training Quality and Teaching Reform Project
- National Natural Science Foundation of China
Zitieren
APA
Liu, W., Yang, Z., Zhang, H., Yang, M., Zhong, C., Li, X., Miao, Y., Li, G. B., Wang, H. L., & Yang, L. (2026). SIRT5 Deacylation Specificity: From Structural Insights and Pathophysiological Functions to Modulator Development. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01808
Vancouver
Liu W, Yang Z, Zhang H, Yang M, Zhong C, Li X, et al. SIRT5 Deacylation Specificity: From Structural Insights and Pathophysiological Functions to Modulator Development. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01808
BibTeX
@article{Liu2026,
author = {Liu, Wenyi and Yang, Zhiwen and Zhang, Hang and Yang, Meijun and Zhong, Cuiting and Li, Xindie and Miao, Yichun and Li, Guo-Bo and Wang, Hua-Li and Yang, Lingling},
title = {SIRT5 Deacylation Specificity: From Structural Insights and Pathophysiological Functions to Modulator Development},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01808}
}
EUVIMED